サマリー

消化管運動促進剤（消化管運動促進剤、胃腸運動促進剤、推進剤）とは、消化管の収縮の頻度や強さを高めることで、そのリズムを崩さずに消化管の運動を促進する薬剤の一種である。腹部不快感、膨満感、便秘、胸焼け、吐き気、嘔吐などの消化器症状や、過敏性腸症候群、胃炎、胃不全、機能性ディスペプシアなどの消化器疾患の治療に用いられます。
市場分析と洞察。運動機能改善薬の世界市場
COVID-19のパンデミックにより、運動機能改善薬の世界市場規模は2022年に100万米ドルと推定され、検討期間中のCAGRは%で、2028年には再調整後の市場規模が100万米ドルになると予測されます。この健康危機による経済的変化を十分に考慮した上で、メトクロプラミドは2021年に動注用医薬品の世界市場の%を占めていましたが、COVID-19後の期間には改訂された%のCAGRで成長し、2028年には100万米ドルになると予測されています。一方、Gastroparesisのセグメントは、この予測期間を通じて％のCAGRで変化しています。
中国の運動機能改善薬の市場規模は2021年に百万米ドル、米国と欧州の運動機能改善薬はそれぞれ百万米ドルと百万米ドルとなっています。米国の割合は2021年には％、中国と欧州はそれぞれ％と％で、中国の割合は2028年には％に達し、分析期間中のCAGRは％になると予測されています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州の動注用医薬品市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中のCAGRは%です。
プロキネティック・ドラッグの世界的な主要メーカーには、住友製薬、ジョンソン・エンド・ジョンソン、サノフィ、協和キリン製薬、ファイザー、テバ、カディラ・ファーマシューティカルズ、ハンミ・ファームなどがあります。2021年には、世界のトップ5社の売上高シェアは約%となっています。
世界のプロキネティック医薬品のスコープとセグメント
Prokinetic Drug市場は、タイプ別、アプリケーション別に分類されています。世界のプロキネティックドラッグ市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年の期間におけるタイプ別、アプリケーション別の売上高、収益、予測に焦点を当てています。
タイプ別セグメント
Metoclopramide（メトクロプラミド
ドンペリドン
シサプリド
その他
用途別セグメント
胃不全麻痺
便秘
逆流性食道炎
機能性ディスペプシア
会社別
住友製薬
ジョンソン・エンド・ジョンソン
サノフィ
協和キリン製薬
ファイザー
テバ
カディラ薬品
ハンミファム
地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 Prokinetic Drug Product Introduction
1.2 Market by Type
1.2.1 Global Prokinetic Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Metoclopramide
1.2.3 Domperidone
1.2.4 Cisapride
1.2.5 Others
1.3 Market by Application
1.3.1 Global Prokinetic Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Gastroparesis
1.3.3 Constipation
1.3.4 Reflux Esophagitis
1.3.5 Functional Dyspepsia
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prokinetic Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Prokinetic Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Prokinetic Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Prokinetic Drug Sales by Region
2.4.1 Global Prokinetic Drug Sales by Region (2017-2022)
2.4.2 Global Sales Prokinetic Drug by Region (2023-2028)
2.5 Global Prokinetic Drug Revenue by Region
2.5.1 Global Prokinetic Drug Revenue by Region (2017-2022)
2.5.2 Global Prokinetic Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prokinetic Drug Sales by Manufacturers
3.1.1 Global Top Prokinetic Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Prokinetic Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prokinetic Drug in 2021
3.2 Global Prokinetic Drug Revenue by Manufacturers
3.2.1 Global Prokinetic Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Prokinetic Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Prokinetic Drug Revenue in 2021
3.3 Global Prokinetic Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prokinetic Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prokinetic Drug Sales by Type
4.1.1 Global Prokinetic Drug Historical Sales by Type (2017-2022)
4.1.2 Global Prokinetic Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Prokinetic Drug Sales Market Share by Type (2017-2028)
4.2 Global Prokinetic Drug Revenue by Type
4.2.1 Global Prokinetic Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Prokinetic Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Prokinetic Drug Revenue Market Share by Type (2017-2028)
4.3 Global Prokinetic Drug Price by Type
4.3.1 Global Prokinetic Drug Price by Type (2017-2022)
4.3.2 Global Prokinetic Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Prokinetic Drug Sales by Application
5.1.1 Global Prokinetic Drug Historical Sales by Application (2017-2022)
5.1.2 Global Prokinetic Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Prokinetic Drug Sales Market Share by Application (2017-2028)
5.2 Global Prokinetic Drug Revenue by Application
5.2.1 Global Prokinetic Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Prokinetic Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Prokinetic Drug Revenue Market Share by Application (2017-2028)
5.3 Global Prokinetic Drug Price by Application
5.3.1 Global Prokinetic Drug Price by Application (2017-2022)
5.3.2 Global Prokinetic Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Prokinetic Drug Market Size by Type
6.1.1 North America Prokinetic Drug Sales by Type (2017-2028)
6.1.2 North America Prokinetic Drug Revenue by Type (2017-2028)
6.2 North America Prokinetic Drug Market Size by Application
6.2.1 North America Prokinetic Drug Sales by Application (2017-2028)
6.2.2 North America Prokinetic Drug Revenue by Application (2017-2028)
6.3 North America Prokinetic Drug Market Size by Country
6.3.1 North America Prokinetic Drug Sales by Country (2017-2028)
6.3.2 North America Prokinetic Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Prokinetic Drug Market Size by Type
7.1.1 Europe Prokinetic Drug Sales by Type (2017-2028)
7.1.2 Europe Prokinetic Drug Revenue by Type (2017-2028)
7.2 Europe Prokinetic Drug Market Size by Application
7.2.1 Europe Prokinetic Drug Sales by Application (2017-2028)
7.2.2 Europe Prokinetic Drug Revenue by Application (2017-2028)
7.3 Europe Prokinetic Drug Market Size by Country
7.3.1 Europe Prokinetic Drug Sales by Country (2017-2028)
7.3.2 Europe Prokinetic Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prokinetic Drug Market Size by Type
8.1.1 Asia Pacific Prokinetic Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Prokinetic Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Prokinetic Drug Market Size by Application
8.2.1 Asia Pacific Prokinetic Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Prokinetic Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Prokinetic Drug Market Size by Region
8.3.1 Asia Pacific Prokinetic Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Prokinetic Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Prokinetic Drug Market Size by Type
9.1.1 Latin America Prokinetic Drug Sales by Type (2017-2028)
9.1.2 Latin America Prokinetic Drug Revenue by Type (2017-2028)
9.2 Latin America Prokinetic Drug Market Size by Application
9.2.1 Latin America Prokinetic Drug Sales by Application (2017-2028)
9.2.2 Latin America Prokinetic Drug Revenue by Application (2017-2028)
9.3 Latin America Prokinetic Drug Market Size by Country
9.3.1 Latin America Prokinetic Drug Sales by Country (2017-2028)
9.3.2 Latin America Prokinetic Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prokinetic Drug Market Size by Type
10.1.1 Middle East and Africa Prokinetic Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Prokinetic Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Prokinetic Drug Market Size by Application
10.2.1 Middle East and Africa Prokinetic Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Prokinetic Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Prokinetic Drug Market Size by Country
10.3.1 Middle East and Africa Prokinetic Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Prokinetic Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sumitomo
11.1.1 Sumitomo Corporation Information
11.1.2 Sumitomo Overview
11.1.3 Sumitomo Prokinetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sumitomo Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sumitomo Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Prokinetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Johnson & Johnson Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson & Johnson Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Prokinetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Kyowa Kirin Pharmaceuticals
11.4.1 Kyowa Kirin Pharmaceuticals Corporation Information
11.4.2 Kyowa Kirin Pharmaceuticals Overview
11.4.3 Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Kyowa Kirin Pharmaceuticals Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kyowa Kirin Pharmaceuticals Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Prokinetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Teva
11.6.1 Teva Corporation Information
11.6.2 Teva Overview
11.6.3 Teva Prokinetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Recent Developments
11.7 Cadila Pharmaceuticals
11.7.1 Cadila Pharmaceuticals Corporation Information
11.7.2 Cadila Pharmaceuticals Overview
11.7.3 Cadila Pharmaceuticals Prokinetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cadila Pharmaceuticals Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cadila Pharmaceuticals Recent Developments
11.8 Hanmi Pharm
11.8.1 Hanmi Pharm Corporation Information
11.8.2 Hanmi Pharm Overview
11.8.3 Hanmi Pharm Prokinetic Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Hanmi Pharm Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hanmi Pharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prokinetic Drug Industry Chain Analysis
12.2 Prokinetic Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prokinetic Drug Production Mode & Process
12.4 Prokinetic Drug Sales and Marketing
12.4.1 Prokinetic Drug Sales Channels
12.4.2 Prokinetic Drug Distributors
12.5 Prokinetic Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prokinetic Drug Industry Trends
13.2 Prokinetic Drug Market Drivers
13.3 Prokinetic Drug Market Challenges
13.4 Prokinetic Drug Market Restraints
14 Key Findings in The Global Prokinetic Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer